Abstract:BACKGROUND AND AIMS: Cleidocranial dysplasia (CCD) represents a rare autosomal dominant skeletal dysplasia caused by mutations that induce haploinsufficiency in RUNX2, the important transcription factor of osteoblasts related to bone/cartilage development and maintenance. Clavicular hypoplasia, which involves aberrant tooth/craniofacial bone/skeletal formation, is a feature of classic CCD. RUNX2 mutations can be found in approximately 60-70% of patients with CCD, and around ∼10% of these mutations are microdeletions. The present paper describes the radiological and clinical characteristics of a 5-year-old girl who showed representative CCD features, including extra teeth, aplasia of clavicles, sloping shoulders, marked calvarial hypomineralization, and osteoporosis.MATERIALS AND METHODS: We obtained genomic DNA of her family members and performed whole-genome sequencing (WGS) for samples collected from the proband. Quantitative fluorescent PCR (QF-PCR) and specific PCR plus electrophoresis were then performed as validation assays for all participants. In vitro analysis was performed. Luciferase assay for Runx2 transcription activity and evaluation of mRNA levels of Runx2 downstream osteogenic markers were conducted.RESULTS: WGS identified a 11.38-kb microdeletion in RUNX2 comprising 8-9 exons, which was validated by QF-PCR and specific PCR plus electrophoresis. In vitro experiments confirmed the pathogenicity of this variation.CONCLUSION: The present study identified a 11.38-kb microdeletion in RUNX2 that causes CCD. The deletion in the PST domain of RUNX2 reduces its transcription activity and reduces osteogenic marker levels, eventually decreasing the differentiation of osteoblasts. These findings clarify the role of the CCD-related mechanism in the development of CCD and suggest that it is important to consider copy number variation for the suspected familial patients early.

Cleidocranial Dysplasia: a Case Report and Gene Mutation Analysis.

Mutation Analysis of the RUNX2 Gene in a Family with Cleidocranial Dysplasia

A Novel RUNX2 Mutation in Cleidocranial Dysplasia Patients.

Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia.

Clinical Spectrum of Cleidocranial Dysplasia in a Family with Twins

Effect of Cleidocranial Dysplasia‐related Novel Mutation of RUNX2 on Characteristics of Dental Pulp Cells and Tooth Development

[Cleidocranial Dysplasia: Two Cases Report and Signature Analysis].

Mutations in the RUNX2 gene in a patient with Cleidocranial Dysplasia

Combined Orthodontic-Surgical Sequential Treatment of Cleidocranial Dysplasia

Effect of the RUNX2 Gene Mutations on Subnuclear Localization of the RUNX2 Protein Mutants

Clinical Features and Diagnosis of Cleidocranial Dysplasia

I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration.

Mutational Analysis of Runx2 Gene in Chinese Patients with Cleidocranial Dysplasia

[Gene Mutation Detection in a Cleidocranial Dysplasia Family].

A novel single-base deletion of the RUNX Family Transcription Factor 2 gene associated with cleidocranial dysplasia

Cleidocranial dysplasia: a case report

Development of the rhesus monkey retina: II. A three‐dimensional analysis of the sequences o synaptic combinations in the inner plexiform layer

Genome sequencing identified a novel exonic microdeletion in the RUNX2 gene that causes cleidocranial dysplasia

Viremia and serological responses in adult chickens infected with western equine encephalomyelitis and St. Louis encephalitis viruses.

Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.

Complex segregation analysis of deafness in Dalmatians.